A 2012 feasibility study with 60 randomized individuals completing 8 weeks of therapy. Results suggests: “A significant difference, favoring CST, was noted by treatment group in mean headache hours per day 30 days post treatment (1.89 vs. 2.78, p=0.003). HIT-6 scores decreased significantly in both groups, but without a between-group difference at the last treatment visit. MIDAS scores improved in the CST, but not the LSSM group at 4 weeks post treatment. Headache intensity was reduced more in the CST compared with the LSSM group” Further protocol modifications needed to enhance future research of CST for migraines.
References:
Research: J Mann, S Gaylord, K Faurot, C Suchindran, R Coeytaux, L Wilkinson, R Coble, P Curtis. “P02.55. Craniosacral therapy for migraine: a feasibility study”. BMC Complement Altern Med. 2012; 12(Suppl 1): P111.
Samantha Lotti is a Doctor of Acupuncture and Chinese Medicine (DACM), a licensed acupuncturist (L.Ac.), a certified and registered Biodynamic Craniosacral Therapist (BCST, RCST®), holds a Bachelor of Science in Nutrition, and is a board-certified herbalist.